Gastrointestinal malignancy and the microbiome

Gastroenterology

Volumn 146, Issue 6, 2014, Pages

  Abreu, Maria T ^a   Peek Jr , Richard M ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacteria; Cancer; Inflammation

Indexed keywords

PROBIOTIC AGENT;

ANTIGEN RECOGNITION; ARTICLE; COLON CANCER; COLON FLORA; COLON POLYP; DIET; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; METABOLITE; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; VIRUS;

BACTERIA; CANCER; INFLAMMATION;

ANIMALS; BACTERIA; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PROBIOTICS; RISK FACTORS;

EID: 84898793295     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.001     Document Type: Article

References (141)

1. I. Cho, and M.J. Blaser The human microbiome: at the interface of health and disease Nat Rev Genet 13 2012 260 270
2. C.S. Plottel, and M.J. Blaser Microbiome and malignancy Cell Host Microbe 10 2011 324 335
3. C. de Martel, J. Ferlay, and S. Franceschi et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
4. D.B. Polk, and R.M. Peek Jr. Helicobacter pylori: gastric cancer and beyond Nat Rev Cancer 10 2010 403 414
5. L.E. Wroblewski, and R.M. Peek H. pylori in gastric carcinogenesis: mechanisms Gastroenterol Clin North Am 42 2013 285 298
6. S. Odenbreit, J. Puls, and B. Sedlmaier et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion Science 287 2000 1497 1500
7. W. Fischer, J. Puls, and R. Buhrdorf et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8 Mol Microbiol 42 2001 1337 1348
8. T. Kwok, D. Zabler, and S. Urman et al. Helicobacter exploits integrin for type IV secretion and kinase activation Nature 449 2007 862 866
9. C.L. Shaffer, J.A. Gaddy, and J.T. Loh et al. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface PLoS Pathog 7 2011 e1002237
10. M.J. Blaser, G.I. Perez-Perez, and H. Kleanthous et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach Cancer Res 55 1995 2111 2115
11. D. Mueller, N. Tegtmeyer, and S. Brandt et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains J Clin Invest 122 2012 1553 1566
12. H. Higashi, R. Tsutsumi, and S. Muto et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 2002 683 686
13. I. Saadat, H. Higashi, and C. Obuse et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity Nature 447 2007 330 333
14. M.R. Amieva, R. Vogelmann, and A. Covacci et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA Science 300 2003 1430 1434
15. A.T. Franco, D.A. Israel, and M.K. Washington et al. Activation of ß-catenin by carcinogenic Helicobacter pylori Proc Natl Acad Sci U S A 102 2005 10646 10651
16. N. Murata-Kamiya, Y. Kurashima, and Y. Teishikata et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells Oncogene 26 2007 4617 4626
17. T.A. Nagy, L.E. Wroblewski, and D. Wang et al. ß-Catenin and p120 mediate PPARdelta-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia Gastroenterology 141 2011 553 564
18. S. Brandt, T. Kwok, and R. Hartig et al. NF-kB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein Proc Natl Acad Sci U S A 102 2005 9300 9305
19. R. Chaturvedi, M. Asim, and J. Romero-Gallo et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA Gastroenterology 141 2011 1696 1708
20. T.L. Cover, and S.R. Blanke Helicobacter pylori VacA, a paradigm for toxin multifunctionality Nat Rev Microbiol 3 2005 320 332
21. J.C. Atherton, P. Cao, and R.M. Peek Jr. et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration J Biol Chem 270 1995 17771 17777
22. J.L. Rhead, D.P. Letley, and M. Mohammadi et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer Gastroenterology 133 2007 926 936
23. S. Backert, and N. Tegtmeyer The versatility of the Helicobacter pylori vacuolating cytotoxin VacA in signal transduction and molecular crosstalk Toxins 2 2010 69 92
24. N. Barker, M. Huch, and P. Kujala et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro Cell Stem Cell 6 2010 25 36
25. T. Uehara, D. Ma, and Y. Yao et al. H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer Dig Dis Sci 58 2013 140 149
26. J.L. Guruge, P.G. Falk, and R.G. Lorenz et al. Epithelial attachment alters the outcome of Helicobacter pylori infection Proc Natl Acad Sci U S A 95 1998 3925 3930
27. A.J. Syder, J.L. Guruge, and Q. Li et al. Helicobacter pylori attaches to NeuAc alpha 2,3Gal beta 1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells Mol Cell 3 1999 263 274
28. A.J. Syder, J.D. Oh, and J.L. Guruge et al. The impact of parietal cells on Helicobacter pylori tropism and host pathology: an analysis using gnotobiotic normal and transgenic mice Proc Natl Acad Sci U S A 100 2003 3467 3472
29. J.D. Oh, H. Kling-Backhed, and M. Giannakis et al. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression Proc Natl Acad Sci U S A 103 2006 9999 10004
30. H. Tsugawa, H. Suzuki, and H. Saya et al. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells Cell Host Microbe 12 2012 764 777
31. L.A. Noach, N.B. Bosma, and J. Jansen et al. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection Scand J Gastroenterol 29 1994 425 429
32. E.M. El-Omar, M. Carrington, and W.H. Chow et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 2000 398 402
33. C. Figueiredo, J.C. Machado, and P. Pharoah et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma J Natl Cancer Inst 94 2002 1680 1687
34. E. Garza-Gonzalez, F.J. Bosques-Padilla, and E. El-Omar et al. Role of the polymorphic IL-1B, IL-1RN, and TNF-a genes in distal gastric cancer in Mexico Int J Cancer 114 2005 237 241
35. J. Mayerle, C.M. den Hoed, and C. Schurmann et al. Identification of genetic loci associated with Helicobacter pylori serologic status JAMA 309 2013 1912 1920
36. J.M. Noto, J.A. Gaddy, and J.Y. Lee et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans J Clin Invest 123 2013 479 492
37. J.L. Ma, L. Zhang, and L.M. Brown et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality J Natl Cancer Inst 104 2012 488 492
38. D.R. Riley, K.B. Sieber, and K.M. Robinson et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples PLoS Comput Biol 9 2013 e1003107
39. J. Fox, and A. Sheh The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis Gut Microbes 4 2013 30 55
40. E.M. Bik, P.B. Eckburg, and S.R. Gill et al. Molecular analysis of the bacterial microbiota in the human stomach Proc Natl Acad Sci U S A 103 2006 732 737
41. A.F. Andersson, M. Lindberg, and H. Jakobsson et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing PLoS One 3 2008 e2836
42. A. Maldonado-Contreras, K.C. Goldfarb, and F. Godoy-Vitorino et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status ISME J 5 2011 574 579
43. I. Yang, S. Nell, and S. Suerbaum Survival in hostile territory: the microbiota of the stomach FEMS Microbiol Rev 37 2013 736 761
44. J. Dicksved, M. Lindberg, and M. Rosenquist et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls J Med Microbiol 58 2009 509 516
45. T. Watanabe, M. Tada, and H. Nagai et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils Gastroenterology 115 1998 642 648
46. S. Honda, T. Fujioka, and M. Tokieda et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils Cancer Res 58 1998 4255 4259
47. K. Ogura, S. Maeda, and M. Nakao et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil J Exp Med 192 2000 1601 1610
48. R.M. Peek, H.P. Wirth, and S.F. Moss et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils Gastroenterology 118 2000 48 59
49. D.A. Israel, N. Salama, and C.N. Arnold et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses J Clin Invest 107 2001 611 620
50. A.T. Franco, E. Johnston, and U. Krishna et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors Cancer Res 68 2008 379 387
51. Y.Q. Sun, H.J. Monstein, and L.E. Nilsson et al. Profiling and identification of eubacteria in the stomach of Mongolian gerbils with and without Helicobacter pylori infection Helicobacter 8 2003 149 157
52. T. Osaki, T. Matsuki, and T. Asahara et al. Comparative analysis of gastric bacterial microbiota in Mongolian gerbils after long-term infection with Helicobacter pylori Microb Pathog 53 2012 12 18
53. Y. Zavros, G. Rieder, and A. Ferguson et al. Gastritis and hypergastrinemia due to Acinetobacter lwoffii in mice Infect Immun 70 2002 2630 2639
54. A.S. Rolig, C. Cech, and E. Ahler et al. The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota Infect Immun 81 2013 1382 1389
55. T. Aebischer, A. Fischer, and A. Walduck et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice FEMS Immunol Med Microbiol 46 2006 221 229
56. M.P. Tan, M. Kaparakis, and M. Galic et al. Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach Appl Environ Microbiol 73 2007 1010 1013
57. J.L. Lofgren, M.T. Whary, and Z. Ge et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia Gastroenterology 140 2011 210 220
58. K. Lertpiriyapong, M.T. Whary, and S. Muthupalani et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis Gut 63 2014 54 63
59. L.B. Lemke, Z. Ge, and M.T. Whary et al. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology Infect Immun 77 2009 2147 2158
60. Z. Ge, Y. Feng, and S. Muthupalani et al. Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice Infect Immun 79 2011 3861 3871
61. M.E. Martin, S. Bhatnagar, and M.D. George et al. The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque PLoS One 8 2013 e76375
62. J. Lagergren, and P. Lagergren Recent developments in esophageal adenocarcinoma CA Cancer J Clin 63 2013 232 248
63. L. Yang, X. Lu, and C.W. Nossa et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome Gastroenterology 137 2009 588 597
64. L. Yang, F. Francois, and Z. Pei Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus Clin Cancer Res 18 2012 2138 2144
65. Y.P. Fan, S. Chakder, and F. Gao et al. Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction Am J Physiol Gastrointest Liver Physiol 280 2001 G32 G42
66. S. Calatayud, E. Garcia-Zaragoza, and C. Hernandez et al. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying Am J Physiol Gastrointest Liver Physiol 283 2002 G1360 G1367
67. B.D. Smith, G.L. Smith, and A. Hurria et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol 27 2009 2758 2765
68. E.R. Fearon Molecular genetics of colorectal cancer Annu Rev Pathol 6 2011 479 507
69. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet 9 1993 138 141
70. C. Dejea, E. Wick, and C.L. Sears Bacterial oncogenesis in the colon Future Microbiol 8 2013 445 460
71. M.L. Slattery, K. Curtin, and C. Sweeney et al. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer Int J Cancer 120 2007 656 663
72. J. Qin, R. Li, and J. Raes et al. A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65
73. J. Walter, and R. Ley The human gut microbiome: ecology and recent evolutionary changes Annu Rev Microbiol 65 2011 411 429
74. C.A. Lozupone, J.I. Stombaugh, and J.I. Gordon et al. Diversity, stability and resilience of the human gut microbiota Nature 489 2012 220 230
75. C. Palmer, E.M. Bik, and D.B. DiGiulio et al. Development of the human infant intestinal microbiota PLoS Biol 5 2007 e177
76. W. Chen, F. Liu, and Z. Ling et al. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer PLoS One 7 2012 e39743
77. A. Jemal, R. Siegel, and E. Ward et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
78. R.B. Gupta, N. Harpaz, and S. Itzkowitz et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 2007 1099 1105
79. J.C. Arthur, E. Perez-Chanona, and M. Muhlbauer et al. Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
80. A. Boleij, M.M. van Gelder, and D.W. Swinkels et al. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis Clin Infect Dis 53 2011 870 878
81. X.J. Shen, J.F. Rawls, and T. Randall et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas Gut Microbes 1 2010 138 147
82. I. Sobhani, J. Tap, and F. Roudot-Thoraval et al. Microbial dysbiosis in colorectal cancer (CRC) patients PLoS One 6 2011 e16393
83. N. Wu, X. Yang, and R. Zhang et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients Microb Ecol 66 2013 462 470
84. T.L. Weir, D.K. Manter, and A.M. Sheflin et al. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults PLoS One 8 2013 e70803
85. M. Castellarin, R.L. Warren, and J.D. Freeman et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res 22 2012 299 306
86. A.D. Kostic, D. Gevers, and C.S. Pedamallu et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma Genome Res 22 2012 292 298
87. A.D. Kostic, E. Chun, and L. Robertson et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment Cell Host Microbe 14 2013 207 215
88. S. Wu, K.J. Rhee, and E. Albesiano et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Nat Med 15 2009 1016 1022
89. H.M. Chen, Y.N. Yu, and J.L. Wang et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma Am J Clin Nutr 97 2013 1044 1052
90. J.R. Marchesi, B.E. Dutilh, and N. Hall et al. Towards the human colorectal cancer microbiome PLoS One 6 2011 e20447
91. A. Hirayama, K. Kami, and M. Sugimoto et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry Cancer Res 69 2009 4918 4925
92. H. Tjalsma, A. Boleij, and J.R. Marchesi et al. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects Nat Rev Microbiol 10 2012 575 582
93. C.L. Sears, and D.M. Pardoll Perspective: alpha-bugs, their microbial partners, and the link to colon cancer J Infect Dis 203 2011 306 311
94. B. Casini, L. Borgese, and F. Del Nonno et al. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues Anticancer Res 25 2005 1079 1085
95. L. Laghi, A.E. Randolph, and D.P. Chauhan et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers Proc Natl Acad Sci U S A 96 1999 7484 7489
96. S. Enam, L. Del Valle, and C. Lara et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin Cancer Res 62 2002 7093 7101
97. H.P. Chen, J.K. Jiang, and C.Y. Chen et al. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis J Clin Virol 54 2012 240 244
98. E.S. Hwang, Z. Zhang, and H. Cai et al. Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein J Virol 83 2009 12388 12398
99. T.H. Chen, C.C. Huang, and K.T. Yeh et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer World J Gastroenterol 18 2012 4051 4058
100. J.B. Greer, and S.J. O'Keefe Microbial induction of immunity, inflammation, and cancer Front Physiol 1 2011 168
101. A.J. Vargas, and P.A. Thompson Diet and nutrient factors in colorectal cancer risk Nutr Clin Pract 27 2012 613 623
102. S.J. O'Keefe Nutrition and colonic health: the critical role of the microbiota Curr Opin Gastroenterol 24 2008 51 58
103. L.H. Augenlicht, J.M. Mariadason, and A. Wilson et al. Short chain fatty acids and colon cancer J Nutr 132 2002 3804S 3808S
104. W. Scheppach Effects of short chain fatty acids on gut morphology and function Gut 35 1994 S35 S38
105. P. Louis, K.P. Scott, and S.H. Duncan et al. Understanding the effects of diet on bacterial metabolism in the large intestine J Appl Microbiol 102 2007 1197 1208
106. K. Windey, V. De Preter, and K. Verbeke Relevance of protein fermentation to gut health Mol Nutr Food Res 56 2012 184 196
107. J.E. Wells, and P.B. Hylemon Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces Appl Environ Microbiol 66 2000 1107 1113
108. J. Ou, F. Carbonero, and E.G. Zoetendal et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans Am J Clin Nutr 98 2013 111 120
109. M. Fukata, and M.T. Abreu TLR4 signalling in the intestine in health and disease Biochem Soc Trans 35 2007 1473 1478
110. S. Rakoff-Nahoum, and R. Medzhitov Innate immune recognition of the indigenous microbial flora Mucosal Immunol 1 Suppl 1 2008 S10 S14
111. M. Asquith, and F. Powrie An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer J Exp Med 207 2010 1573 1577
112. M. Fukata, and M.T. Abreu Microflora in colorectal cancer: a friend to fear Nat Med 16 2010 639 641
113. S. Moossavi, and N. Rezaei Toll-like receptor signalling and their therapeutic targeting in colorectal cancer Int Immunopharmacol 16 2013 199 209
114. R. Santaolalla, D.A. Sussman, and J.R. Ruiz et al. TLR4 activates the beta-catenin pathway to cause intestinal neoplasia PLoS One 8 2013 e63298
115. J. Lascorz, K. Hemminki, and A. Forsti Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development J Carcinog 10 2011 7
116. M. Saleh, and G. Trinchieri Innate immune mechanisms of colitis and colitis-associated colorectal cancer Nat Rev Immunol 11 2011 9 20
117. M. Fukata, A. Chen, and A.S. Vamadevan et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 133 2007 1869 1881
118. M. Fukata, L. Shang, and R. Santaolalla et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis Inflamm Bowel Dis 17 2011 1464 1473
119. E.L. Lowe, T.R. Crother, and S. Rabizadeh et al. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer PLoS One 5 2010 e13027
120. R. Salcedo, A. Worschech, and M. Cardone et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 J Exp Med 207 2010 1625 1636
121. S. Rakoff-Nahoum, and R. Medzhitov Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 Science 317 2007 124 127
122. S.H. Lee, L.L. Hu, and J. Gonzalez-Navajas et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice Nat Med 16 2010 665 670
123. S.I. Grivennikov, K. Wang, and D. Mucida et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
124. A.R. Moser, H.C. Pitot, and W.F. Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 324
125. Y. Li, P. Kundu, and S.W. Seow et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice Carcinogenesis 33 2012 1231 1238
126. D.A. Sussman, R. Santaolalla, and S. Strobel et al. Cancer in inflammatory bowel disease: lessons from animal models Curr Opin Gastroenterol 28 2012 327 333
127. S.E. Erdman, T. Poutahidis, and M. Tomczak et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice Am J Pathol 162 2003 691 702
128. C.M. Nagamine, A.B. Rogers, and J.G. Fox et al. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice Int J Cancer 122 2008 832 838
129. J.M. Uronis, M. Muhlbauer, and H.H. Herfarth et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility PLoS One 4 2009 e6026
130. A. Couturier-Maillard, T. Secher, and A. Rehman et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer J Clin Invest 123 2013 700 711
131. K. Klimesova, M. Kverka, and Z. Zakostelska et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice Inflamm Bowel Dis 19 2013 1266 1277
132. M.R. Rubinstein, X. Wang, and W. Liu et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin Cell Host Microbe 14 2013 195 206
133. G. Cuevas-Ramos, C.R. Petit, and I. Marcq et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells Proc Natl Acad Sci U S A 107 2010 11537 11542
134. M.M. Huycke, V. Abrams, and D.R. Moore Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA Carcinogenesis 23 2002 529 536
135. M.M. Huycke, and D.R. Moore In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation Free Radic Biol Med 33 2002 818 826
136. X. Wang, and M.M. Huycke Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells Gastroenterology 132 2007 551 561
137. I.M. Carroll, J.M. Andrus, and J.M. Bruno-Barcena et al. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis Am J Physiol Gastrointest Liver Physiol 293 2007 G729 G738
138. Y. Zhu, T. Michelle Luo, and C. Jobin et al. Gut microbiota and probiotics in colon tumorigenesis Cancer Lett 309 2011 119 127
139. L. Gianotti, L. Morelli, and F. Galbiati et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients World J Gastroenterol 16 2010 167 175
140. H. Ishikawa, I. Akedo, and T. Otani et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors Int J Cancer 116 2005 762 767
141. A. Swidsinski, M. Khilkin, and D. Kerjaschki et al. Association between intraepithelial Escherichia coli and colorectal cancer Gastroenterology 115 1998 281 286